bucillamine: Clinical Trials

2 trials of bucillamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Terminated 1

Follow bucillamine: new trials by email Literature Review of bucillamine trials Research Report on bucillamine

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bucillamine in Treatment of Patients With COVID-19
Bucillamine, Placebo - Covid19
Phase 3TerminatedRevive Therapeutics, Ltd.7132020-11-272023-07-07
A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)
Sarilumab, Sulfasalazine, Leflunomide - Rheumatoid Arthritis
Phase 3CompletedSanofi912015-02-012018-01-30

Conditions studied

Arthritis, Rheumatoid (1)  ·  COVID-19 (1)

Sponsors

Revive Therapeutics, Ltd. (1)  ·  Sanofi (1)

Countries

Japan (1)  ·  Puerto Rico (1)  ·  United States (1)